ATE380867T1 - Lactoferrinrezeptorgen von moraxella - Google Patents

Lactoferrinrezeptorgen von moraxella

Info

Publication number
ATE380867T1
ATE380867T1 AT98925352T AT98925352T ATE380867T1 AT E380867 T1 ATE380867 T1 AT E380867T1 AT 98925352 T AT98925352 T AT 98925352T AT 98925352 T AT98925352 T AT 98925352T AT E380867 T1 ATE380867 T1 AT E380867T1
Authority
AT
Austria
Prior art keywords
moraxella
lactoferrin receptor
nucleic acid
receptor gene
proteins
Prior art date
Application number
AT98925352T
Other languages
English (en)
Inventor
Sheena Loosmore
Run-Pan Du
Quijun Wang
Yan-Ping Yang
Michel Klein
Original Assignee
Sanofi Pasteur Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26755908&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE380867(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/867,941 external-priority patent/US5977337A/en
Application filed by Sanofi Pasteur Ltd filed Critical Sanofi Pasteur Ltd
Application granted granted Critical
Publication of ATE380867T1 publication Critical patent/ATE380867T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98925352T 1997-06-03 1998-06-02 Lactoferrinrezeptorgen von moraxella ATE380867T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/867,941 US5977337A (en) 1997-06-03 1997-06-03 Lactoferrin receptor genes of Moraxella
US09/074,658 US6184371B1 (en) 1997-06-03 1998-05-08 Lactoferrin receptor genes of Moraxella

Publications (1)

Publication Number Publication Date
ATE380867T1 true ATE380867T1 (de) 2007-12-15

Family

ID=26755908

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98925352T ATE380867T1 (de) 1997-06-03 1998-06-02 Lactoferrinrezeptorgen von moraxella

Country Status (8)

Country Link
EP (1) EP1000144B1 (de)
JP (1) JP2001502925A (de)
AT (1) ATE380867T1 (de)
AU (1) AU739129B2 (de)
BR (1) BR9809914A (de)
CA (1) CA2292838A1 (de)
NZ (1) NZ501911A (de)
WO (1) WO1998055606A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE459373T1 (de) 1999-03-19 2010-03-15 Glaxosmithkline Biolog Sa Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
GB9914870D0 (en) * 1999-06-25 1999-08-25 Smithkline Beecham Sa Novel compounds
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
US20060057160A1 (en) 2002-08-02 2006-03-16 Ralph Biemans Vaccine composition
RU2247373C2 (ru) * 2003-04-28 2005-02-27 Нижегородская государственная медицинская академия Способ экспресс-диагностики и дифференциальной диагностики урогенитальных инфекций
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
KR101515078B1 (ko) 2005-12-22 2015-04-24 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
MY150105A (en) 2006-01-17 2013-11-29 Forsgren Arne A novel surface exposed haemophilus influenzae protein (protein e; pe)
CA2690708A1 (en) 2007-06-26 2008-12-31 Glaxosmithkline Biologicals S.A. Vaccine
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
CA2792687A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
GB2600653B (en) 2017-05-30 2022-11-02 Glaxosmithkline Biologicals Sa Novel methods
BR112020010790A2 (pt) 2017-12-01 2020-11-10 Glaxosmithkline Biologicals S.A. purificação da saponina
EP3833382A1 (de) 2018-08-07 2021-06-16 GlaxoSmithKline Biologicals S.A. Verfahren und impfstoffe
EP3886901A1 (de) 2018-11-29 2021-10-06 GlaxoSmithKline Biologicals S.A. Verfahren zur herstellung eines adjuvans
WO2020245207A1 (en) 2019-06-05 2020-12-10 Glaxosmithkline Biologicals Sa Saponin purification
GB202205833D0 (en) 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage
EP4558170A1 (de) 2022-07-19 2025-05-28 GlaxoSmithKline Biologicals S.A. Kontinuierliches verfahren zur herstellung von impfstoffen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3335622B2 (ja) * 1989-04-27 2002-10-21 ユニバーシティ テクノロジーズ インターナショナル インコーポレイテッド 細菌からトランスフェリン及びラクトフェリン受容体タンパク質を分離及び精製する方法並びにこれらを含有するワクチンを調製する方法
US5292869A (en) * 1989-04-27 1994-03-08 The Board Of Governors Of The University Method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same
US6048539A (en) * 1995-11-02 2000-04-11 Connaught Laboratories Limited Lactoferrin receptor protein

Also Published As

Publication number Publication date
JP2001502925A (ja) 2001-03-06
CA2292838A1 (en) 1998-12-10
BR9809914A (pt) 2001-09-18
AU739129B2 (en) 2001-10-04
EP1000144A2 (de) 2000-05-17
AU7753498A (en) 1998-12-21
WO1998055606A2 (en) 1998-12-10
WO1998055606A3 (en) 1999-03-04
EP1000144B1 (de) 2007-12-12
NZ501911A (en) 2001-12-21

Similar Documents

Publication Publication Date Title
ATE380867T1 (de) Lactoferrinrezeptorgen von moraxella
DE69434839D1 (de) Transferrin-rezeptor gene von haemophilus
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
DE69131580D1 (de) GDF-1 und UOG1 Proteine
RU95115239A (ru) Аналог эритропоэтина
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
DE69117949D1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
BR9711795A (pt) Peptìdeos tendo propriedades antiproliferativas
EP0261403A3 (de) Polypeptide des Rhinovirusstammes HRV89 sowie die hierfür codierenden DNA-Moleküle
MD20000034A (ro) Proteinele virusului răsucirii frunzelor de viţă de vie (tipul 2) şi utilizarea lor
RU2214273C2 (ru) ДНК-ПОСЛЕДОВАТЕЛЬНОСТИ, КОДИРУЮЩИЕ ЧЕЛОВЕЧЕСКИЕ ПРОТЕИНЫ Tx И Ty, РОДСТВЕННЫЕ КОНВЕРГИРУЮЩЕМУ ИНТЕРЛЕЙКИН-1-β ФЕРМЕНТУ
EP1905831A3 (de) Lactoferrin-Rezeptorgene von Moraxella
DE69633179D1 (de) Transferrinrezeptorgene
DE69233155D1 (de) Insulinartigen wachstumsfaktor bindendes protein
NO874704L (no) Minaktivin fremstilt ved rekombinant dna-teknikk.
PT990000E (pt) Factor 3 de crescimento do tecido conjuntivo
DK0616642T3 (da) Hidtil ukendte thrombininhibitoriske proteiner fra landblodigler
NO962596L (no) Nytt tumorsupressorgen
KR950003312A (ko) 연골세포 단백질
WO1999052947A3 (en) TRANSFERRIN RECEPTOR GENES OF $i(MORAXELLA)
ATE193324T1 (de) Rekombinante herstellung von laktoperoxidase
DE69925927D1 (de) Mutmassliches 98 kd protein des aussenmembrans von chlamydia und dafür kodierende dns sowie deren verwendung
MX9709527A (es) Genes receptores de transferrina.
WO2001046412A3 (de) Interaktionsprotein für stat transkriptionsfaktor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1000144

Country of ref document: EP

REN Ceased due to non-payment of the annual fee